Progression of MM at early onset is driven by abnormally low levels of apoptosis, a high mitotic rate, and increased transendothelial migration of myeloma cells, partially mediated by TNF through NF-κB activation [100,101]. The gene discussed is NFKB1; the disease is plasma cell myeloma.